Ateba Resources Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ateba resources inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ateba Resources Inc Today - Breaking & Trending Today

Glow Lifetech Corp.: Glow LifeTech to Commence Trading on the CSE on March 15, 2021 Under the Symbol GLOW


Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain forward-looking information within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as plan , expect , project , intend , believe , anticipate , estimate and other similar words, or statements that certain events or conditions may or will occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company s control. There are no assura ....

W Clark Kent , Kostenloser Wertpapierhandel , Clark Kent , Ateba Resources Inc The Company , Newsfile Corp , Mycell Technology , Canadian Securities Exchange , Glow Lifetech Corp , Ateba Resources Inc , டப்ல்யூ கிளார்க் கேண்ட் , கிளார்க் கேண்ட் , கனடியன் பத்திரங்கள் பரிமாற்றம் , பளபளப்பு ஆயுட்காலம் கார்ப் ,

Glow Lifetech Corp.: Glow LifeTech Corp. Announces Completion of Business Combination


Glow Lifetech Corp.: Glow LifeTech Corp. Announces Completion of Business Combination
Company ) is pleased to announce that the Company has completed its previously announced business combination (the
Transaction ) with Glow LifeTech Ltd. (
Glow Ltd. ), whereby the Company acquired all of the issued and outstanding shares of Glow pursuant to a three-cornered amalgamation in accordance with Section 174 of the
Business Corporations Act (Ontario), as further described below.
The common shares of the Company have been conditionally approved for listing (the
Listing ) on the Canadian Securities Exchange (the
CSE ) under the symbol GLOW . The Listing remains subject to final approval by the CSE and fulfilment of all of the requirements of the CSE in order to obtain such approval, including, among other things, submission and acceptance of all documents requested by the CSE in its conditional acceptance letter and payment of all outstanding fees to t ....

James Van Staveren , Roberto Carducci , Clark Kent , Chris Irwin , W Clark Kent , Kostenloser Wertpapierhandel , Chris Hopkins , Greg Falck , Medhanie Tekeste , Ateba Resources Inc The Company , Glow Ltd , Glow Lifetech Ltd , Consideration Shares Of The Company , Glow Lifetech Corp , Newsfile Corp , Mycell Technology , Company To Glow Lifetech Corp , Canadian Securities Exchange , Ateba Resources Inc , Glow Lifetech , Business Corporations Act , Business Combination Agreement , Glow Shareholders , Glow Warrants , Replacement Warrants , Chief Commercial Officer ,

Relay Medical Corp.: Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology


(2)
Glow LifeTech has the exclusive rights for MyCell Technology in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC, a COVID-19 Treatment Candidate with successful Phase II Clinical Results
The formulation statistically significantly improved the clinical recovery of COVID-19 patients in the treatment group in comparison with placebo and 100% of the patients in the treatment group fully recovered within 15 days
Positive results from a phase II double blind randomized controlled clinical trial show the MyCell Technology ArtemiC formulation, successfully met the primary and secondary endpoints for safety and efficacy
1
ArtemiC is a natural anti-inflammatory formulation by Glow partner Swiss PharmaCan and MGC Pharma, intended to suppress cytokine storm and clinical deterioration prevention to support the recovery of COVID-19 patients ....

United States , W Clark Kent , Clark Kent , Bernhard Langer , Relay Medical Corp , Glow Mycell Technology , Glow Lifetech Ltd , Pharmaceuticals Ltd , Mycell Technology Artemi , Swiss Pharmacan Ag Micelle Technology , Mycell Technology , Micelle Technology , Placebo Group , Canadian Securities Exchange , Ateba Resources Inc , Glow Lifetech , Mycell Technology Artemic , Swiss Pharmacan , North American , Boswellia Serrata , Chief Executive Officer , North America , With Glow , Managing Director , Ateba Resources , Medi Cal ,